News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Reardon Tighe
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $14.02, valued at
$1.5M
|
|
| 01/05/2022 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 116,750 options to buy
@ $20.24, valued at
$2.4M
|
|
| 06/16/2021 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Converted 2,696,843 shares
@ $0
Converted 1,153,238 shares
@ $0
Bought 629,411 shares
@ $17, valued at
$10.7M
Converted 2,105,264 convertible preferred
@ $0
Converted 900,264 convertible preferred
@ $0 |
|
| 06/10/2021 |
3
| Reardon Tighe (Acting CFO) has filed a Form 3 on Janux Therapeutics, Inc. |
| 01/24/2020 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Unknown transaction of 43,688 shares
@ $68, valued at
$3M
Unknown transaction of 1,682,086 shares
@ $68, valued at
$114.4M
Disposed/sold 18,723 options to buy
@ $4.64, valued at
$86.9k
Disposed/sold 30,000 options to buy
@ $11, valued at
$330k
|
|
| 12/13/2018 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Converted 1,136,631 shares
@ $0
Bought 545,455 shares
@ $11, valued at
$6M
Converted 1,821,156 preferred shares
@ $0 |
|
| 12/07/2018 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Granted 30,000 options to buy
@ $11, valued at
$330k
|
|
| 12/06/2018 |
3
| Reardon Tighe (Acting CFO) has filed a Form 3 on Synthorx, Inc. |
|
|